Efficient Management of First line ALK-rearranged NSCLC - Part VII

Speciality: Oncology


Speaker:

Dr Jogamaya Pattnaik | Assistant Professor - Department of Medical Oncology, KIMS Hospital, Bhubaneswar

Dr Abhishek Kakroo | Senior Consultant Medical and Hemato Oncologist at Hemato Oncology Clinic, Vedanta

Dr B K Smruti | Senior Consultant Medical and Hemato Oncologist at Bombay Hospital and Medical Research Centre

Description:

A warm welcome to all the medical professionals in this interesting session on the efficient management of first-line ALK-rearranged NSCLC.

Efficient management of first-line ALK-rearranged NSCLC involves a multidisciplinary approach integrating targeted therapy, precision diagnostics, and regular monitoring. Early identification of ALK mutations through molecular testing allows for tailored treatment strategies, such as ALK inhibitors, to be initiated promptly, optimizing patient outcomes and minimizing disease progression. 

Close collaboration between oncologists, pathologists, and radiologists ensures comprehensive care delivery, facilitating timely adjustments to treatment plans based on individual patient responses and evolving disease dynamics.

Therefore, get an overall knowledge on the efficient management of first-line ALK rearranged NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC

2.

Virtual Reality Travel Reduces Cancer Pain.

3.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

4.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

5.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot